Dependence of correlations between antibody titres and opsonophagocytosis on pneumococcal serotype and patient morbidity in pre- and post-pneumococcal.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Vaccines for the elderly
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period  J. Liñares, C. Ardanuy, R. Pallares, A.
Gut bacterial microbiota and obesity
Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis  C.G. Baxter, D.W. Denning, A.M.
Approach to diagnosis of infective endocarditis
R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz 
Varicella vaccination: a laboured take-off
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia 
Migrant health—a cause for concern?
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
A guide to interpreting economic studies in infectious diseases
Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children  N. Agrinier, M. Le Maréchal,
R. Cantón  Clinical Microbiology and Infection 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Prevalence of Toscana virus antibodies in residents of Croatia
Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine  E. Calbo, Á. Díaz, E.
Vector control: a cornerstone in the malaria elimination campaign
The role of vaccination in preventing pneumococcal disease in adults
A. Solé, P. Morant, M. Salavert, J. Pemán, P. Morales 
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
R. Karakus, K. Caglar, C. Aybay  Clinical Microbiology and Infection 
Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes  S. Ladhani,
Levofloxacin in the treatment of ventilator-associated pneumonia
Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study  M.R. Berndsen,
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults*   P. Durando, S.N. Faust,
Metagenomics and probiotics
M. Aires-de-Sousa  Clinical Microbiology and Infection 
A case of pleurisy associated with antibodies to Rickettsia conorii
The practice of travel medicine in Europe
Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989–2008)  C. Esteva, L. Selva, M.F.
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Changes in Streptococcus pneumoniae serotypes causing invasive disease with non- universal vaccination coverage of the seven-valent conjugate vaccine 
Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients  S. Oliveri, L. Trovato, P. Betta, M.G. Romeo,
Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection  R. Nir-Paz, A. Michael-Gayego, M. Ron, C.
Current experience in treating invasive zygomycosis with posaconazole
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Vaccines for the elderly
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Leishmaniasis in immunosuppressed individuals
M. Pirisi, E. Salvador, Z. Bisoffi, M. Gobbo, C. Smirne, C. Gigli, R
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Genomic diversity of group A rotavirus strains in patients aged 1–36 months admitted for acute watery diarrhoea in northern India: a hospital-based study 
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Metagenomics of human microbiome: beyond 16s rDNA
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Three years experience of real-time PCR for the diagnosis of Q fever
Community-acquired acute bacterial meningitis in the elderly in Turkey
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Dependence of correlations between antibody titres and opsonophagocytosis on pneumococcal serotype and patient morbidity in pre- and post-pneumococcal vaccination states  D. Tarragó, L. Aguilar, W.T.M. Jansen, M.J. Giménez, A. Avellón, J.J. Granizo, J. Casal  Clinical Microbiology and Infection  Volume 13, Issue 4, Pages 369-376 (April 2007) DOI: 10.1111/j.1469-0691.2006.01677.x Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Distribution of antibody concentrations (ELISA) and opsonophagocytic activity (OPA) titres pre-vaccination (open circles; dotted line) and post-vaccination (black squares; continous line) for serotypes 6, 14 and 23 in elderly patients. Clinical Microbiology and Infection 2007 13, 369-376DOI: (10.1111/j.1469-0691.2006.01677.x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Distribution of antibody concentrations (ELISA) and opsonophagocytic activity (OPA) titres pre-vaccination (open circles; dotted line) and post-vaccination (black squares; continous line) for serotypes 6, 14 and 23 in haemodialysed patients. Clinical Microbiology and Infection 2007 13, 369-376DOI: (10.1111/j.1469-0691.2006.01677.x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 3 Distribution of antibody concentrations (ELISA) and opsonophagocytic activity (OPA) titres pre-vaccination (open circles; dotted line) and post-vaccination (black squares; continous line) for serotypes 6, 14 and 23 in renal transplant recipients. Clinical Microbiology and Infection 2007 13, 369-376DOI: (10.1111/j.1469-0691.2006.01677.x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.